Testing effectiveness (Phase 2)Study completedNCT00278395
What this trial is testing
Vorinostat in Treating Patients With Kidney Cancer
Who this might be right for
Recurrent Renal Cell CarcinomaStage IV Renal Cell Cancer
National Cancer Institute (NCI) 14